|
1
|
Aozasa K, Takakuwa T, Hongyo T and Yang
WI: Nasal NK/T-cell lymphoma: Epidemiology and pathogenesis. Int J
Hematol. 87:110–117. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Harabuchi Y, Imai S, Wakashima J, Hirao M,
Kataura A, Osato T and Kon S: Nasal T-cell lymphoma causally
associated with Epstein-Barr virus: Clinicopathologic, phenotypic,
and genotypic studies. Cancer. 77:2137–2149. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Petrova M and Kamburov V: Epstein-Barr
virus: Silent companion or causative agent of chronic liver
disease? World J Gastroenterol. 16:4130–4134. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Zheng ZM: Viral oncogenes, noncoding RNAs,
and RNA splicing in human tumor viruses. Int J Biol Sci. 6:730–755.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kung CP and Raab-Traub N: Epstein-Barr
virus latent membrane protein 1 induces expression of the epidermal
growth factor receptor through effects on Bcl-3 and STAT3. J Virol.
82:5486–5493. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Guasparri I, Bubman D and Cesarman E: EBV
LMP2A affects LMP1-mediated NF-kappaB signaling and survival of
lymphoma cells by regulating TRAF2 expression. Blood.
111:3813–3820. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Chen H, Hutt-Fletcher L, Cao L and Hayward
SD: A positive autoregulatory loop of LMP1 expression and STAT
activation in epithelial cells latently infected with Epstein-Barr
virus. J Virol. 77:4139–4148. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Peng M and Lundgren E: Transient
expression of the Epstein-Barr virus LMP1 gene in human primary B
cells induces cellular activation and DNA synthesis. Oncogene.
7:1775–1782. 1992.PubMed/NCBI
|
|
9
|
Ambrosini G, Adida C and Altieri DC: A
novel anti-apoptosis gene, survivin, expressed in cancer and
lymphoma. Nat Med. 3:917–921. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Cheung CH, Huang CC, Tsai FY, Lee JY,
Cheng SM, Chang YC, Huang YC, Chen SH and Chang JY: Survivin -
biology and potential as a therapeutic target in oncology. Onco
Targets Ther. 6:1453–1462. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Waligórska-Stachura J, Jankowska A, Waśko
R, Liebert W, Biczysko M, Czarnywojtek A, Baszko-Błaszyk D, Shimek
V and Ruchała M: Survivin - prognostic tumor biomarker in human
neoplasms - review. Ginekol Pol. 83:537–540. 2012.
|
|
12
|
Ng SB, Selvarajan V, Huang G, et al:
Activated oncogenic pathways and therapeutic targets in extranodal
nasal-type NK/T cell lymphoma revealed by gene expression
profiling. J Pathol. 223:496–510. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Aktaş S, Kargi A, Olgun N, Diniz G, Erbay
A and Vergin C: Prognostic significance of cell proliferation and
apoptosis-regulating proteins in Epstein-Barr Virus positive and
negative pediatric non-Hodgkin’s lymphoma. Pathol Oncol Res.
15:345–350. 2009. View Article : Google Scholar
|
|
14
|
Devergne O, Cahir McFarland ED, Mosialos
G, Izumi KM, Ware CF and Kieff E: Role of the TRAF binding site and
NF-kappaB activation in Epstein-Barr virus latent membrane protein
1-induced cell gene expression. J Virol. 72:7900–7908.
1998.PubMed/NCBI
|
|
15
|
Tomayko MM and Reynolds CP: Determination
of subcutaneous tumor size in athymic (nude) mice. Cancer Chemother
Pharmacol. 24:148–154. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ma L, Deng X, Wu M, Zhang G and Huang J:
Down-regulation of miRNA-204 by LMP-1 enhances CDC42 activity and
facilitates invasion of EBV-associated nasopharyngeal carcinoma
cells. FEBS Lett. 588:1562–1570. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zhao Y, Pang TY, Wang Y, et al: LMP1
stimulates the transcription of eIF4E to promote the proliferation,
migration and invasion of human nasopharyngeal carcinoma. FEBS J.
281:3004–3018. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kanavaros P, Briere J, Emile JF and
Gaulard P: Epstein-Barr virus in T and natural killer (NK) cell
non-Hodgkin’s lymphomas. Leukemia. 10(Suppl 2): s84–s87. 1996.
|
|
19
|
Nagata H, Konno A, Kimura N, Zhang Y,
Kimura M, Demachi A, Sekine T, Yamamoto K and Shimizu N:
Characterization of novel natural killer (NK)-cell and gammadelta
T-cell lines established from primary lesions of nasal T/NK-cell
lymphomas associated with the Epstein-Barr virus. Blood.
97:708–713. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Komabayashi Y, Kishibe K, Nagato T, Ueda
S, Takahara M and Harabuchi Y: Downregulation of miR-15a due to
LMP1 promotes cell proliferation and predicts poor prognosis in
nasal NK/T-cell lymphoma. Am J Hematol. 89:25–33. 2014. View Article : Google Scholar
|
|
21
|
Sarela AI, Macadam RC, Farmery SM, Markham
AF and Guillou PJ: Expression of the antiapoptosis gene, survivin,
predicts death from recurrent colorectal carcinoma. Gut.
46:645–650. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Endo K, Shackelford J, Aga M, Yoshizaki T
and Pagano JS: Upregulation of special AT-rich-binding protein 1 by
Epstein-Barr virus latent membrane protein 1 in human
nasopharyngeal cells and nasopharyngeal cancer. J Gen Virol.
94:507–513. 2013. View Article : Google Scholar :
|
|
23
|
Faqing T, Zhi H, Liqun Y, Min T, Huanhua
G, Xiyun D and Ya C: Epstein-Barr virus LMP1 initiates cell
proliferation and apoptosis inhibition via regulating expression of
Survivin in nasopharyngeal carcinoma. Exp Oncol. 27:96–101.
2005.PubMed/NCBI
|
|
24
|
Ai MD, Li LL, Zhao XR, Wu Y, Gong JP and
Cao Y: Regulation of survivin and CDK4 by Epstein-Barr virus
encoded latent membrane protein 1 in nasopharyngeal carcinoma cell
lines. Cell Res. 15:777–784. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Thornburg NJ, Kulwichit W, Edwards RH,
Shair KH, Bendt KM and Raab-Traub N: LMP1 signaling and activation
of NF-kappaB in LMP1 transgenic mice. Oncogene. 25:288–297.
2006.
|
|
26
|
Hino R, Uozaki H, Inoue Y, Shintani Y,
Ushiku T, Sakatani T, Takada K and Fukayama M: Survival advantage
of EBV-associated gastric carcinoma: Survivin up-regulation by
viral latent membrane protein 2A. Cancer Res. 68:1427–1435. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Lee JW, Liu PF, Hsu LP, Chen PR, Chang CH
and Shih WL: EBV LMP-1 negatively regulates expression and
pro-apoptotic activity of Par-4 in nasopharyngeal carcinoma cells.
Cancer Lett. 279:193–201. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Han I, Yun M, Kim EO, Kim B, Jung MH and
Kim SH: Umbilical cord tissue-derived mesenchymal stem cells induce
apoptosis in PC-3 prostate cancer cells through activation of JNK
and down-regulation of PI3K/AKT signaling. Stem Cell Res Ther.
5:542014. View
Article : Google Scholar
|
|
29
|
Ou DL, Lee BS, Lin LI, Liou JY, Liao SC,
Hsu C and Cheng AL: Vertical blockade of the IGFR- PI3K/Akt/mTOR
pathway for the treatment of hepatocellular carcinoma: The role of
survivin. Mol Cancer. 13:22014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Roberts ML and Cooper NR: Activation of a
ras-MAPK-dependent pathway by Epstein-Barr virus latent membrane
protein 1 is essential for cellular transformation. Virology.
240:93–99. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Spadavecchia S, Gonzalez-Lopez O, Carroll
KD, Palmeri D and Lukac DM: Convergence of Kaposi’s
sarcoma-associated herpes-virus reactivation with Epstein-Barr
virus latency and cellular growth mediated by the notch signaling
pathway in coinfected cells. J Virol. 84:10488–10500. 2010.
View Article : Google Scholar : PubMed/NCBI
|
